ClinCalc Pro
Menu
Selective MET kinase inhibitor

Tepotinib (Specialist drug)

Brand names: Tepmetko

Adult dose

Dose: Specialist initiation only — refer to BNF/SmPC
Route: PO
Frequency: OD

Clinical pearls

  • MET exon 14 skipping NSCLC
  • Specialist oncology

Contraindications

  • Severe hepatic impairment
  • Hypersensitivity

Side effects

  • Peripheral oedema
  • Hypoalbuminaemia
  • ILD/pneumonitis
  • Hepatotoxicity
  • Increased creatinine

Interactions

  • P-gp/BCRP substrates
  • Acid-reducing agents

Monitoring

  • LFTs
  • Pulmonary symptoms
  • Albumin

Reference: BNF; NICE TA789; SmPC; https://bnf.nice.org.uk/drugs/tepotinib-specialist-drug/. Verify against your local formulary and the latest BNF before prescribing.

Related

Curated clinical cross-links plus same-class fallbacks.